{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T10:56:49Z","timestamp":1776164209457,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","ejpn-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Paediatric Neurology"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.ejpn.2017.03.001","type":"journal-article","created":{"date-parts":[[2017,3,14]],"date-time":"2017-03-14T06:01:06Z","timestamp":1489471266000},"page":"621-626","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Clonidine use in the outpatient management of\u00a0severe secondary dystonia"],"prefix":"10.1016","volume":"21","author":[{"given":"C.","family":"Sayer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.E.","family":"Lumsden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Kaminska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9314-2259","authenticated-orcid":false,"given":"J.-P.","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.ejpn.2017.03.001_bib1","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/mds.25475","article-title":"Phenomenology and classification of dystonia: a consensus update","volume":"28","author":"Albanese","year":"2013","journal-title":"Mov Disord"},{"issue":"11","key":"10.1016\/j.ejpn.2017.03.001_bib2","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1136\/jnnp-2013-307041","article-title":"The impact and prognosis for dystonia in childhood including dystonic cerebral palsy: a clinical and demographic tertiary cohort study","volume":"85","author":"Lin","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"10.1016\/j.ejpn.2017.03.001_bib3","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.ejpn.2016.02.006","article-title":"Progression to musculoskeletal deformity in childhood dystonia","volume":"20","author":"Lumsden","year":"2016","journal-title":"Eur J Paediatr Neurol"},{"issue":"10","key":"10.1016\/j.ejpn.2017.03.001_bib4","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1111\/j.1468-1331.2011.03649.x","article-title":"Treatment for dystonia in childhood","volume":"19","author":"Roubertie","year":"2012","journal-title":"Eur J Neurol"},{"issue":"6","key":"10.1016\/j.ejpn.2017.03.001_bib5","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1468-1331.2004.00845.x","article-title":"Efficacy of pharmacological treatment of dystonia: evidence-based review including meta-analysis of the effect of botulinum toxin and other cure options","volume":"11","author":"Balash","year":"2004","journal-title":"Eur J Neurol"},{"issue":"7","key":"10.1016\/j.ejpn.2017.03.001_bib6","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1002\/mds.25548","article-title":"Special concerns in defining, studying, and treating dystonia in children","volume":"28","author":"Mink","year":"2013","journal-title":"Mov Disord"},{"issue":"4","key":"10.1016\/j.ejpn.2017.03.001_bib7","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.ejpn.2016.02.003","article-title":"Medication use in chilhood dystonia","volume":"20","author":"Lumsden","year":"2016","journal-title":"Eur J Paediatr Neurology"},{"issue":"1","key":"10.1016\/j.ejpn.2017.03.001_bib8","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ejpn.2015.09.007","article-title":"Gabapentin can significantly improve dystonia severity and quality of life in children","volume":"20","author":"Liow","year":"2016","journal-title":"Eur J Paediatr Neurol"},{"issue":"7","key":"10.1016\/j.ejpn.2017.03.001_bib9","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S1474-4422(16)00132-0","article-title":"Advances in management of movement disorders in children","volume":"15","author":"Koy","year":"2016","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ejpn.2017.03.001_bib10","doi-asserted-by":"crossref","first-page":"15082","DOI":"10.1038\/nrdp.2015.82","article-title":"Cerebral palsy","volume":"2","author":"Graham","year":"2016","journal-title":"Nat Rev Dis Prim"},{"issue":"5","key":"10.1016\/j.ejpn.2017.03.001_bib11","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2165\/00003088-198814050-00002","article-title":"Clinical pharmacokinetics of clonidine","volume":"14","author":"Lowenthal","year":"1988","journal-title":"Clin Pharmacokinet"},{"issue":"7","key":"10.1016\/j.ejpn.2017.03.001_bib12","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/j.1460-9592.2006.02185.x","article-title":"Effects of preanesthetic administration of midazolam, clonidine, or dexmedetomidine on postoperative pain and anxiety in children","volume":"17","author":"Schmidt","year":"2007","journal-title":"Paediatr Anaesth"},{"issue":"8","key":"10.1016\/j.ejpn.2017.03.001_bib13","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1007\/s00134-004-2319-0","article-title":"Use of oral clonidine for sedation in ventilated paediatric intensive care patients","volume":"30","author":"Arenas-Lopez","year":"2004","journal-title":"Intensive Care Med"},{"issue":"4","key":"10.1016\/j.ejpn.2017.03.001_bib14","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/BF01705163","article-title":"Clonidine as a sedative\u00a0adjunct in intensive care","volume":"16","author":"Bohrer","year":"1990","journal-title":"Intensive Care Med"},{"issue":"6","key":"10.1016\/j.ejpn.2017.03.001_bib15","doi-asserted-by":"crossref","first-page":"e1406","DOI":"10.1542\/peds.2010-1260","article-title":"Clonidine extended-release tablets as add-on therapy to psychostimulants in children and adolescents with ADHD","volume":"127","author":"Kollins","year":"2011","journal-title":"Pediatrics"},{"issue":"11","key":"10.1016\/j.ejpn.2017.03.001_bib16","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1136\/adc.2007.128728","article-title":"When to use drugs to help sleep","volume":"93","author":"Gringras","year":"2008","journal-title":"Arch Dis Child"},{"issue":"3","key":"10.1016\/j.ejpn.2017.03.001_bib17","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1177\/070674371205700302","article-title":"Canadian guidelines for the evidence-based treatment of tic disorders: pharmacotherapy","volume":"57","author":"Pringsheim","year":"2012","journal-title":"Can J Psychiatry"},{"issue":"4","key":"10.1016\/j.ejpn.2017.03.001_bib18","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00787-011-0163-7","article-title":"European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatment","volume":"20","author":"Roessner","year":"2011","journal-title":"Eur Child Adolesc Psychiatry"},{"issue":"5","key":"10.1016\/j.ejpn.2017.03.001_bib19","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.ejpn.2011.04.005","article-title":"Movement disorder emergencies in childhood","volume":"15","author":"Kirkham","year":"2011","journal-title":"Eur J Paediatr Neurology EJPN Official J Eur Paediatr Neurology Soc"},{"key":"10.1016\/j.ejpn.2017.03.001_bib20","doi-asserted-by":"crossref","first-page":"965932","DOI":"10.1155\/2012\/965932","article-title":"Paroxysmal autonomic instability with dystonia after pneumococcal meningoencephalitis","volume":"2012","author":"Safadieh","year":"2012","journal-title":"Case Rep Med"},{"issue":"12","key":"10.1016\/j.ejpn.2017.03.001_bib21","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1177\/7010.2006.00134","article-title":"Oral baclofen and clonidine for treatment of spasticity in children","volume":"21","author":"Lubsch","year":"2006","journal-title":"J Child Neurol"},{"issue":"3","key":"10.1016\/j.ejpn.2017.03.001_bib22","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1460-9592.2010.03397.x","article-title":"Oral bioavailability of clonidine in children","volume":"21","author":"Larsson","year":"2011","journal-title":"Paediatr Anaesth"},{"issue":"3","key":"10.1016\/j.ejpn.2017.03.001_bib23","first-page":"115","article-title":"Effects of premedication of midazolam or clonidine on perioperative anxiety and pain in children","volume":"3","author":"Cao","year":"2009","journal-title":"Biosci Trends"},{"issue":"2","key":"10.1016\/j.ejpn.2017.03.001_bib24","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0196-0644(81)80350-2","article-title":"Clonidine overdose: report of six cases and review of the literature","volume":"10","author":"Anderson","year":"1981","journal-title":"Ann Emerg Med"},{"issue":"4","key":"10.1016\/j.ejpn.2017.03.001_bib25","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1469-8749.1997.tb07414.x","article-title":"Development and reliability of a system to classify gross motor function in children with cerebral palsy","volume":"39","author":"Palisano","year":"1997","journal-title":"Dev Med Child Neurol"},{"issue":"3","key":"10.1016\/j.ejpn.2017.03.001_bib26","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.ejpn.2013.12.010","article-title":"Evaluation of functional goal outcomes using the Canadian occupational performance measure (COPM) following deep brain stimulation (DBS) in childhood dystonia","volume":"18","author":"Gimeno","year":"2014","journal-title":"Eur J Paediatr Neurol"},{"issue":"2","key":"10.1016\/j.ejpn.2017.03.001_bib27","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/dmcn.12965","article-title":"Burke-Fahn-Marsden dystonia severity, Gross Motor, Manual Ability, And Communication Function Classification scales in childhood hyperkinetic movement disorders including cerebral palsy: a\u00a0'Rosetta Stone' study","volume":"58","author":"Elze","year":"2016","journal-title":"Dev Med Child Neurol"},{"issue":"7","key":"10.1016\/j.ejpn.2017.03.001_bib28","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1177\/0883073810392582","article-title":"Trihexyphenidyl improves motor function in children with dystonic cerebral palsy: a retrospective analysis","volume":"26","author":"Ben-Pazi","year":"2011","journal-title":"J Child Neurol"},{"issue":"2","key":"10.1016\/j.ejpn.2017.03.001_bib29","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jpainsymman.2004.05.002","article-title":"Comparative efficacy and safety of skeletal muscle relaxants for spasticity and musculoskeletal conditions: a systematic review","volume":"28","author":"Chou","year":"2004","journal-title":"J Pain Symptom Manage"},{"issue":"Suppl. 1","key":"10.1016\/j.ejpn.2017.03.001_bib30","first-page":"69","article-title":"Use of enteral, intravenous, and transdermal Clonidine for the acute management of severe intractable childhood dystonia","volume":"58","author":"Nakou","year":"2016","journal-title":"Dev Med Child Neurol"},{"issue":"2","key":"10.1016\/j.ejpn.2017.03.001_bib31","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/dmcn.12339","article-title":"Status dystonicus: a\u00a0practice guide","volume":"56","author":"Allen","year":"2014","journal-title":"Dev Med Child Neurol"},{"issue":"7","key":"10.1016\/j.ejpn.2017.03.001_bib32","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/dmcn.12108","article-title":"Dystonia Severity Action Plan: a simple grading system for medical severity of status dystonicus and life-threatening dystonia","volume":"55","author":"Lumsden","year":"2013","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.ejpn.2017.03.001_bib33","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3389\/fneur.2016.00226","article-title":"Recognizing the common origins of dystonia and the development of human movement: a manifesto of unmet needs in isolated childhood dystonias","volume":"7","author":"Lin","year":"2016","journal-title":"Front Neurol"},{"key":"10.1016\/j.ejpn.2017.03.001_bib34","unstructured":"https:\/\/www.aacpdm.org\/publications\/care-pathways\/dystonia."}],"container-title":["European Journal of Paediatric Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379817301630?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379817301630?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T14:05:51Z","timestamp":1568901951000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1090379817301630"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S1090379817301630"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpn.2017.03.001","relation":{},"ISSN":["1090-3798"],"issn-type":[{"value":"1090-3798","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clonidine use in the outpatient management of\u00a0severe secondary dystonia","name":"articletitle","label":"Article Title"},{"value":"European Journal of Paediatric Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpn.2017.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Ltd on behalf of European Paediatric Neurology Society.","name":"copyright","label":"Copyright"}]}}